Alzheimer’s drug lecanemab hailed as momentous breakthrough


One of many world’s main researchers behind the entire concept of concentrating on amyloid 30 years in the past, Prof John Hardy, mentioned it was “historic” and was optimistic “we’re seeing the start of Alzheimer’s therapies”. Prof Tara Spires-Jones, from the College of Edinburgh, mentioned the outcomes had been “a giant deal as a result of we have had a 100% failure charge for a very long time”.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *